Spatial navigation testing discriminates two types of amnestic mild cognitive impairment

Area of Science:

• Neuroscience
• Cognitive Psychology
• Gerontology

Background:

• The hippocampus is crucial for memory consolidation and spatial navigation.
• Alzheimer's disease (AD) diagnosis is often preceded by mild cognitive impairment (MCI).
• Amnestic MCI (aMCI) may represent distinct subgroups with varying spatial navigation abilities.

Purpose of the Study:

• To investigate if amnestic MCI (aMCI) consists of two subgroups: hippocampal (HaMCI) and non-hippocampal (NHaMCI) memory impairment.
• To compare spatial navigation abilities between these subgroups, controls, and Alzheimer's disease (AD) patients.
• To determine if spatial navigation deficits in aMCI correlate with preclinical AD.

Main Methods:

• Classified 52 patients into non-amnestic MCI (naMCI), hippocampal aMCI (HaMCI), and non-hippocampal aMCI (NHaMCI) subgroups.
• Compared these groups with healthy controls and AD patients using the Hidden Goal Task.
• Assessed egocentric and allocentric spatial navigation to evaluate learning and memory capacity.

Main Results:

• The HaMCI group demonstrated significantly poorer spatial navigation performance compared to the NHaMCI group.
• HaMCI patients showed limited learning capacity in later trials, unlike NHaMCI patients who exhibited learning effects.
• HaMCI group performance closely mirrored that of the AD group.

Conclusions:

• Spatial navigation deficits are pronounced in individuals with hippocampal memory impairment within MCI.
• These deficits may serve as an indicator for preclinical Alzheimer's disease.
• Distinguishing between hippocampal and non-hippocampal memory impairment in MCI is critical for understanding disease progression.